| HOME >> BIOLOGY >> TECHNOLOGY |
BALTIMORE, March 18 /PRNewswire/ -- Alba Therapeutics Corporation today announced that Blake M. Paterson M.D., its CEO and Co-founder, has received the 2008 Leadership in Bioscience Award from the Greater Baltimore Council. Dr. Paterson was recognized from a field of distinguished nominees submitted by businesses, bioscience advocates, higher education institutions and government officials. This is the second successive time that Dr. Paterson has received this award from the Greater Baltimore Council.
Dr. Paterson's leadership accomplishments were examined for evidence of outstanding management practices that led to significant improvement in the company's performance, vision and steps taken to move toward fulfillment of that vision, fostering pioneering work with new or important applications in bioscience, and fundraising achievements. The award was presented today at a breakfast reception hosted by the Greater Baltimore Committee, the region's most prominent organization of business and civic leaders, to recognize outstanding achievements in the region's bioscience industry.
"It is a great honor to receive this award, and it is gratifying to be honored within the Baltimore bioscience and business community," stated Dr. Paterson. "Our goal at Alba has been to work with the 3 P's which include place, people, and perseverance. We are proud to be in the place of Baltimore, our people are working hard to create a new medicine for the unmet medical needs of patients with celiac disease and other inflammatory conditions, and our perseverance and determination toward achieving this goal is what drives us each day. This award recognizes the progress that Alba has made in the past year, and this provides further encouragement in our efforts to address the needs of patients and physicians, to provide value to our investors, and to increase the profile of the Baltimore bioscience community within the region and nationally."
Dr. Paterson has direct
'/>"/>
| SOURCE Alba Therapeutics Corporation Copyright©2008 PR Newswire. All rights reserved |